MP Healthcare Venture Management Inc Overview
Company Details
Founded in 2006, is a subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC). The firm invests in seed to late-stage life sciences ventures based principally in North America and Europe. MPH focuses on medical diagnostics, biotechnology, vaccines and therapeutics. Specific areas of interest include: Cardiology, Stroke, Metabolic disease, Nephrology, Immunology and Inflammation, and Neuroscience.
Notable investments include: Covagen (acquired by Cilag), f-star Biotech (acquired by Bristol-Myers Squibb), Genocea Biosciences (NASDAQ: GNCA), Intradigm Corporation (acquired by Silence Therapeutics),PharmEste S.r.l. and Pronota NV.
Locations
WSO Company Database Comparison Table
or Want to Sign up with your social account?